Syrrx, Inc. Researchers Report Atomic Structure Of c-KIT In Complex With Gleevec
10/19/2005 5:11:54 PM
Syrrx Inc., a next-generation, structure-based drug discovery company, today reported the publication of an article further describing the atomic structure of c-Kit kinase in complex with Novartis' cancer drug Gleevec(R) (also known as STI-571). Syrrx and Novartis are independently using the solved structure to design new anti-cancer agents.
comments powered by